BamSEC and AlphaSense Join Forces
Learn More

Zosano Pharma Corp

Formerly OTC: ZSANQ
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 3 pages Lessee Has Advised Lessor That It Intends to Repay All Amounts Due and Owing Under the Lease Agreements and Has Requested That Lessor Provide Lessee With Appropriate Pay-Off Amounts Owing by Lessee to Lessor Under the Lease Documents (As Defined Below). the Pay-Off Amounts Due to Lessor From Lessee as of May 20, 2022 (The “Computation Date”) Under the Lease Documents Is as Follows (The “Pay-Off Amount”): Pay-Off Amounts
12/34/56
EX-10.6
from 10-Q 1 page Material contract
12/34/56
EX-10.44
from 10-K/A 8 pages Zosano Pharma Corporation Retention Bonus Plan 1. Purpose
12/34/56
EX-10.43
from 10-K 5 pages Second Amendment to Lease Documents
12/34/56
EX-10.42
from 10-K 8 pages Zosano Pharma Corporation Amended and Restated 2014 Equity and Incentive Plan Performance Stock Unit Award Grant Notice
12/34/56
EX-10.41
from 10-K 3 pages Nonstatutory Stock Option Granted by Zosano Pharma Corporation (The “Company”) Under the Amended and Restated 2014 Equity and Incentive Plan
12/34/56
EX-10.40
from 10-K 3 pages [****] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Not Material and Would Likely Cause Competitive Harm to the Registrant if Publicly Disclosed. Cope Part A: Project Overview Executive Summary of the Opportunity [****] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Not Material and Would Likely Cause Competitive Harm to the Registrant if Publicly Disclosed. Part B: Pricing
12/34/56
EX-10.2
from 8-K 4 pages Voting Agreement
12/34/56
EX-10.1
from 8-K 18 pages Zosano Pharma Corporation and Computershare, Inc. and Computershare Trust Company, N.A., as Warrant Agent Warrant Agency Agreement Dated as of February 10, 2022 Warrant Agency Agreement
12/34/56
EX-10.1
from 8-K 2 pages Amendment No. 1 to Master Services Agreement
12/34/56
EX-10.2
from 10-Q 10 pages Material contract
12/34/56
EX-10.1
from 8-K 45 pages Zosano Pharma Corporation Shares of Common Stock (Par Value $0.0001 Per Share) Controlled Equity Offeringsm Sales Agreement
12/34/56
EX-10.37
from 10-K 3 pages Zosano Pharma Corporation Non-Employee Director Compensation Program
12/34/56
EX-10.3
from 10-Q 45 pages Material contract
12/34/56
EX-10.3
from 10-Q 7 pages Zosano Pharma Corporation Amended and Restated 2014 Equity and Incentive Plan Restricted Stock Unit Award Grant Notice
12/34/56
EX-10.2
from 8-K 3 pages Amendment No. 1 to Business Understanding Agreement
12/34/56
EX-10.2
from 10-Q 2 pages Nonstatutory Stock Option Granted by Zosano Pharma Corporation (The “Company”) Under the Amended and Restated 2014 Equity and Incentive Plan
12/34/56
EX-10.1
from 10-Q 3 pages Incentive Stock Option Granted by Zosano Pharma Corporation (The “Company”) Under the Amended and Restated 2014 Equity and Incentive Plan
12/34/56
EX-10.1
from 8-K 6 pages Business Understanding Agreement
12/34/56
EX-10.1
from 8-K 50 pages Zosano Pharma Corporation Up to $20,000,000 of Common Stock (Par Value $0.0001 Per Share) At-The-Market Sales Agreement
12/34/56